Evonik Industries AG products

The RESOMER portfolio of bioresorbable polymers has earned a strong track record for efficacy, biocompatibility, safety and supply security over more than 30 years of commercial use. This portfolio of semi-crystalline and amorphous polymers are available in a range of standard and customizable forms to provide maximum versatility in the development of innovative bioresorbable devices.

2-Propanol, 1-[4-[[2-(1-methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-, (2E)-2-butenedioate (2:1).